116 related articles for article (PubMed ID: 38817206)
1. Repurposing the antihistamine drug bilastine as an anti-cancer metallic drug entity: synthesis and single-crystal X-ray structure analysis of metal-based bilastine and phen [Co(II), Cu(II) and Zn(II)] tailored anticancer chemotherapeutic agents against resistant cancer cells.
Rijwan ; Arjmand F; Tabassum S
Dalton Trans; 2024 Jun; 53(24):10126-10141. PubMed ID: 38817206
[TBL] [Abstract][Full Text] [Related]
2. Structure elucidation {spectroscopic, single crystal X-ray diffraction and computational DFT studies} of new tailored benzenesulfonamide derived Schiff base copper(II) intercalating complexes: Comprehensive biological profile {DNA binding, pBR322 DNA cleavage, Topo I inhibition and cytotoxic activity}.
Afsan Z; Roisnel T; Tabassum S; Arjmand F
Bioorg Chem; 2020 Jan; 94():103427. PubMed ID: 31735357
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Transition Metal Complexes of Benzimidazole-Derived Scaffold as Promising Anticancer Chemotherapeutics.
Hussain A; AlAjmi MF; Rehman MT; Khan AA; Shaikh PA; Khan RA
Molecules; 2018 May; 23(5):. PubMed ID: 29883398
[TBL] [Abstract][Full Text] [Related]
4. Protein binding studies with human serum albumin, molecular docking and in vitro cytotoxicity studies using HeLa cervical carcinoma cells of Cu(ii)/Zn(ii) complexes containing a carbohydrazone ligand.
Parsekar SU; Velankanni P; Sridhar S; Haldar P; Mate NA; Banerjee A; Sudhadevi Antharjanam PK; Koley AP; Kumar M
Dalton Trans; 2020 Mar; 49(9):2947-2965. PubMed ID: 32073070
[TBL] [Abstract][Full Text] [Related]
5. Homo- and heteroleptic trimethoxy terpyridine-Cu(ii) complexes: synthesis, characterization, DNA/BSA binding, DNA cleavage and cytotoxicity studies.
Jain S; Bhar K; Kumar S; Bandyopadhyaya S; Tapryal S; Mandal CC; Sharma AK
Dalton Trans; 2020 Apr; 49(13):4100-4113. PubMed ID: 32141470
[TBL] [Abstract][Full Text] [Related]
6. Cu(II), Mn(II) and Zn(II) complexes of hydrazones with a quaternary ammonium moiety: synthesis, experimental and theoretical characterization and cytotoxic activity.
Stevanović N; Zlatar M; Novaković I; Pevec A; Radanović D; Matić IZ; Đorđić Crnogorac M; Stanojković T; Vujčić M; Gruden M; Sladić D; Anđelković K; Turel I; Čobeljić B
Dalton Trans; 2021 Dec; 51(1):185-196. PubMed ID: 34877947
[TBL] [Abstract][Full Text] [Related]
7. Trizbenzim, Cu-Trizbenzim and Zn-Trizbenzim as G-Quadruplex Inducing and Stabilizing Compounds on Human Telomeric Sequence and their Anticancer Properties.
Renuga D; Maheswari PU; Begum KMMS; Prabaharan D
Anticancer Agents Med Chem; 2021; 21(17):2407-2418. PubMed ID: 33463477
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes.
Anjum R; Palanimuthu D; Kalinowski DS; Lewis W; Park KC; Kovacevic Z; Khan IU; Richardson DR
Inorg Chem; 2019 Oct; 58(20):13709-13723. PubMed ID: 31339305
[TBL] [Abstract][Full Text] [Related]
9. Influence of anchoring moieties on new benzimidazole-based Schiff base copper(II) complexes towards estrogen dependent breast cancer cells.
Paul A; Singh P; Kuznetsov ML; Karmakar A; Guedes da Silva MFC; Koch B; Pombeiro AJL
Dalton Trans; 2021 Mar; 50(10):3701-3716. PubMed ID: 33634805
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, molecular structure, biological properties and molecular docking studies on Mn(II), Co(II) and Zn(II) complexes containing bipyridine-azide ligands.
Thamilarasan V; Jayamani A; Sengottuvelan N
Eur J Med Chem; 2015 Jan; 89():266-78. PubMed ID: 25462243
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity, X-ray crystal structures and spectroscopic characterization of cobalt(II), copper(II) and zinc(II) coordination compounds with 2-substituted benzimidazoles.
Sánchez-Guadarrama O; López-Sandoval H; Sánchez-Bartéz F; Gracia-Mora I; Höpfl H; Barba-Behrens N
J Inorg Biochem; 2009 Sep; 103(9):1204-13. PubMed ID: 19628280
[TBL] [Abstract][Full Text] [Related]
12. New manganese(II), iron(II), cobalt(II), nickel(II) and copper(II) saccharinate complexes of 2,6-bis(2-benzimidazolyl)pyridine as potential anticancer agents.
Icsel C; Yilmaz VT; Aydinlik Ş; Aygun M
Eur J Med Chem; 2020 Sep; 202():112535. PubMed ID: 32653697
[TBL] [Abstract][Full Text] [Related]
13. Zn(ii), Cd(ii) and Hg(ii) saccharinate complexes with 2,6-bis(2-benzimidazolyl)pyridine as promising anticancer agents in breast and lung cancer cell lines via ROS-induced apoptosis.
Icsel C; Yilmaz VT; Aydinlik S; Aygun M
Dalton Trans; 2020 Jun; 49(23):7842-7851. PubMed ID: 32463408
[TBL] [Abstract][Full Text] [Related]
14. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, Crystal Structures and Anticancer Studies of Morpholinyldithiocarbamato Cu(II) and Zn(II) Complexes.
Ajibade PA; Andrew FP; Botha NL; Solomane N
Molecules; 2020 Aug; 25(16):. PubMed ID: 32781741
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cytotoxic activity and genotoxicity of structurally well characterized potent cobalt(II) phen-based antitumor drug entities: An in vitro and in vivo approach.
Khan HY; Ansari MO; Shadab GGHA; Tabassum S; Arjmand F
Bioorg Chem; 2019 Jul; 88():102963. PubMed ID: 31071506
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, X-ray crystal structure, DNA/BSA binding, DNA cleavage and cytotoxicity studies of phenanthroline based copper(II)/zinc(II) complexes.
Wang Q; Mao H; Wang W; Zhu H; Dai L; Chen Y; Tang X
Biometals; 2017 Aug; 30(4):575-587. PubMed ID: 28616784
[TBL] [Abstract][Full Text] [Related]
18. Water soluble transition metal [Ni(II), Cu(II) and Zn(II)] complexes of
Khursheed S; Siddique HR; Tabassum S; Arjmand F
Dalton Trans; 2022 Aug; 51(31):11713-11729. PubMed ID: 35852297
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic insights into a novel chromone-appended Cu(II) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and HepG2 cancer cells.
Yousuf I; Arjmand F; Tabassum S; Toupet L; Khan RA; Siddiqui MA
Dalton Trans; 2015 Jun; 44(22):10330-42. PubMed ID: 25970097
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, spectral, antitumor, antioxidant and antimicrobial studies on Cu(II), Ni(II) and Co(II) complexes of 4-[(1H-Benzoimidazol-2-ylimino)-methyl]-benzene-1,3-diol.
El-wakiel N; El-keiy M; Gaber M
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Aug; 147():117-23. PubMed ID: 25827773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
